November 5, 2015
Convergent Dental Announces FDA Clearance of Osseous Tissue Procedures for Solea at ADA 2015
Washington, D.C.— November 5, 2015 – Convergent Dental, Inc., a privately held dental device company, today announced that Solea®, the first FDA cleared CO2 9.3 micron dental laser for hard and soft tissue, has also been cleared to perform osseous tissue procedures. With this expanded indication, Solea can be used to treat not only cavity preparations and soft tissue surgery, but also bone cutting, shaving, re-contouring and resection. Convergent Dental will be showcasing Solea at ADA 2015 in Washington, D.C. from November 5-10, 2015.
Solea’s osseous tissue clearance allows dentists to perform procedures ablating bone with speed, precision and less bleeding. As a result, patients may experience less post-operative discomfort and faster healing times. These benefits improve the patient experience, reduce chair time and increase the economic impact for a dental practice.
“Convergent Dental’s rapidly expanding clinical indications for Solea is another example of their commitment to innovation,” said Dr. Simon Bernstein. “With this new osseous tissue clearance by the FDA, Solea’s unique 9.3 micron wavelength continues to create the opportunity for minimally invasive dentistry.”
“This osseous tissue clearance is a critical component of our long term grow strategy. It adds even greater value for our current customers who can add more procedures to their repertoire and makes Solea a compelling option for specialists including periodontists and oral surgeons,” said Convergent Dental CEO Michael Cataldo.
Convergent Dental’s focus on continuous innovation has made it the fastest growing all-tissue dental laser company in the United States. Practitioners interested in learning more about Solea and its latest FDA clearance for osseous tissue procedures can email email@example.com or call 1-844-GO-SOLEA.
# # #
About Convergent Dental, Inc.
Convergent Dental, Inc., is a privately owned dental equipment and technology company and developer of Solea®, the world’s first computer-aided, CO2 laser system to ever be cleared by the FDA for hard, soft and osseous tissue indications. The only dental laser system able to deliver virtually anesthesia-free and blood-free procedures, Solea cuts significantly quieter, finer and faster than any other laser-based system in dentistry. Solea’s speed and precision is a result of patented technologies and computer system controls that are unique to Convergent Dental, Inc. For more information visit www.convergentdental.com. Follow the company on Twitter, Facebook, LinkedIn and Google+.